Recursion to Participate in Upcoming Investor Conference
Recursion (RXRX), a clinical stage TechBio company focused on drug discovery, has announced its upcoming participation in the Needham 24th Annual Virtual Healthcare Conference scheduled for April 7, 2025.
Investors and interested parties can access the conference webcasts through the events section of Recursion's Investor Relations website at ir.recursion.com.
Recursion (RXRX), un'azienda TechBio in fase clinica focalizzata sulla scoperta di farmaci, ha annunciato la sua prossima partecipazione alla 24ª Conferenza Virtuale Annuale sulla Salute di Needham programmata per il 7 aprile 2025.
Investitori e parti interessate possono accedere alle trasmissioni in diretta della conferenza tramite la sezione eventi del sito web delle Relazioni con gli Investitori di Recursion all'indirizzo ir.recursion.com.
Recursion (RXRX), una empresa de TechBio en etapa clínica centrada en el descubrimiento de fármacos, ha anunciado su próxima participación en la 24ª Conferencia Virtual Anual de Salud de Needham programada para el 7 de abril de 2025.
Los inversores y partes interesadas pueden acceder a las transmisiones en vivo de la conferencia a través de la sección de eventos del sitio web de Relaciones con Inversores de Recursion en ir.recursion.com.
Recursion (RXRX), 약물 발견에 중점을 둔 임상 단계의 TechBio 회사가 Needham 제24회 연례 가상 의료 컨퍼런스에 참여할 예정이라고 발표했습니다. 이 컨퍼런스는 2025년 4월 7일에 예정되어 있습니다.
투자자 및 관심 있는 분들은 Recursion의 투자자 관계 웹사이트의 이벤트 섹션을 통해 컨퍼런스 웹캐스트에 접근할 수 있습니다. (ir.recursion.com)
Recursion (RXRX), une entreprise TechBio en phase clinique axée sur la découverte de médicaments, a annoncé sa prochaine participation à la 24ème Conférence Virtuelle Annuelle sur la Santé de Needham, prévue pour le 7 avril 2025.
Les investisseurs et parties intéressées peuvent accéder aux webcasts de la conférence via la section événements du site web des Relations avec les Investisseurs de Recursion à l'adresse ir.recursion.com.
Recursion (RXRX), ein klinisches TechBio-Unternehmen, das sich auf die Arzneimittelentdeckung konzentriert, hat seine bevorstehende Teilnahme an der 24. Virtuellen Jahrestagung im Gesundheitswesen von Needham angekündigt, die für den 7. April 2025 geplant ist.
Investoren und Interessierte können die Webcasts der Konferenz über den Veranstaltungsbereich der Investor-Relations-Website von Recursion unter ir.recursion.com abrufen.
- None.
- None.
Salt Lake City, UT, April 01, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today its participation in the following upcoming investor conference:
- Needham 24th Annual Virtual Healthcare Conference — Monday, April 7, 2025
Webcasts may be found in the events section of the Recursion Investor Relations website at ir.recursion.com.
About Recursion
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.
Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montréal, New York, London, Oxford area, and the San Francisco Bay area. Learn more at www.Recursion.com, or connect on X (formerly Twitter) and LinkedIn.
Media Contact Media@Recursion.com Investor Contact Investor@Recursion.com
FAQ
When is Recursion (RXRX) presenting at the Needham Healthcare Conference 2025?
How can investors access Recursion's (RXRX) Needham Conference presentation?
What type of conference is Recursion (RXRX) participating in April 2025?
Is Recursion's (RXRX) Needham Conference presentation virtual or in-person?
